Loading…
Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment
Purpose of Review Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic in patients with granulomatosis with polyangiitis and can sometimes repres...
Saved in:
Published in: | Current allergy and asthma reports 2020-10, Vol.20 (10), p.56-56, Article 56 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3 |
container_end_page | 56 |
container_issue | 10 |
container_start_page | 56 |
container_title | Current allergy and asthma reports |
container_volume | 20 |
creator | Sattui, Sebastian E. Lally, Lindsay |
description | Purpose of Review
Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic in patients with granulomatosis with polyangiitis and can sometimes represent the initial or in some instances the sole manifestation. The objective of this review is to summarize the various clinical manifestations of localized disease in GPA and their treatment.
Recent Findings
Sinonasal disease is seen in up to 90% of patients. Otologic and ocular involvement is also commonly seen. Laryngeal and tracheal disease although less common is associated with significant morbidity and can be therapeutically challenging. Clinicians need to be aware of these localized GPA manifestations as they may be presenting disease features in the absence of other systemic findings. Treatment of localized GPA involves both immunosuppressive and surgical interventions for specific manifestations. Collaboration between specialists including rheumatologists, otolaryngologists, and ophthalmologists is often crucial to ensure optimal outcomes for patients.
Summary
This is a narrative review that provides a comprehensive overview of localized granulomatosis with polyangiitis and current treatment options. |
doi_str_mv | 10.1007/s11882-020-00953-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2423058574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2421634555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3</originalsourceid><addsrcrecordid>eNp9kcFLHDEUxoNUqq79BzyUQC_rYTR5mWRme1uWdhUW3IN6DZmZxGaZSbZJBtG_3qyrLXgQAgm83_e9l_chdEbJBSWkuoyU1jUUBEhByIyzgh6gY8pZWQhG-ZfdG2ZFxQCO0EmMG5JJUsFXdMRAlDXh_BiZlW9Vb591h5dBubH3g0p-jPjRpj947fsn5R6sTTbi6XI9P_-J71WwmV701tksxeugo3ZJJetdxMp1-G7bqaSxd_g2aJWGXD1Fh0b1UX97uyfo7vev28VVsbpZXi_mq6JlFU9FK0QL-TDeNUZ1gjd0Vpd1A0BZl8fnICqolWhIJ6hQpjIzY0oKCkhLGDNsgqZ7323wf0cdkxxsbHXfK6fzrySUwAiveVVm9McHdOPH4PJ0O4oKVnLOMwV7qg0-xqCN3AY7qPAkKZG7FOQ-BZl3K19TkDSLvr9Zj82gu3-S97VngO2BmEvuQYf_vT-xfQE_OpE_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2421634555</pqid></control><display><type>article</type><title>Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment</title><source>Springer Link</source><creator>Sattui, Sebastian E. ; Lally, Lindsay</creator><creatorcontrib>Sattui, Sebastian E. ; Lally, Lindsay</creatorcontrib><description>Purpose of Review
Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic in patients with granulomatosis with polyangiitis and can sometimes represent the initial or in some instances the sole manifestation. The objective of this review is to summarize the various clinical manifestations of localized disease in GPA and their treatment.
Recent Findings
Sinonasal disease is seen in up to 90% of patients. Otologic and ocular involvement is also commonly seen. Laryngeal and tracheal disease although less common is associated with significant morbidity and can be therapeutically challenging. Clinicians need to be aware of these localized GPA manifestations as they may be presenting disease features in the absence of other systemic findings. Treatment of localized GPA involves both immunosuppressive and surgical interventions for specific manifestations. Collaboration between specialists including rheumatologists, otolaryngologists, and ophthalmologists is often crucial to ensure optimal outcomes for patients.
Summary
This is a narrative review that provides a comprehensive overview of localized granulomatosis with polyangiitis and current treatment options.</description><identifier>ISSN: 1529-7322</identifier><identifier>EISSN: 1534-6315</identifier><identifier>DOI: 10.1007/s11882-020-00953-1</identifier><identifier>PMID: 32648055</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Allergology ; Autoimmunity (T Tarrant ; Immunotherapy ; Inflammatory diseases ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Section Editor ; Topical Collection on Autoimmunity ; Vein & artery diseases</subject><ispartof>Current allergy and asthma reports, 2020-10, Vol.20 (10), p.56-56, Article 56</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3</citedby><cites>FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32648055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sattui, Sebastian E.</creatorcontrib><creatorcontrib>Lally, Lindsay</creatorcontrib><title>Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment</title><title>Current allergy and asthma reports</title><addtitle>Curr Allergy Asthma Rep</addtitle><addtitle>Curr Allergy Asthma Rep</addtitle><description>Purpose of Review
Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic in patients with granulomatosis with polyangiitis and can sometimes represent the initial or in some instances the sole manifestation. The objective of this review is to summarize the various clinical manifestations of localized disease in GPA and their treatment.
Recent Findings
Sinonasal disease is seen in up to 90% of patients. Otologic and ocular involvement is also commonly seen. Laryngeal and tracheal disease although less common is associated with significant morbidity and can be therapeutically challenging. Clinicians need to be aware of these localized GPA manifestations as they may be presenting disease features in the absence of other systemic findings. Treatment of localized GPA involves both immunosuppressive and surgical interventions for specific manifestations. Collaboration between specialists including rheumatologists, otolaryngologists, and ophthalmologists is often crucial to ensure optimal outcomes for patients.
Summary
This is a narrative review that provides a comprehensive overview of localized granulomatosis with polyangiitis and current treatment options.</description><subject>Allergology</subject><subject>Autoimmunity (T Tarrant</subject><subject>Immunotherapy</subject><subject>Inflammatory diseases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Section Editor</subject><subject>Topical Collection on Autoimmunity</subject><subject>Vein & artery diseases</subject><issn>1529-7322</issn><issn>1534-6315</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kcFLHDEUxoNUqq79BzyUQC_rYTR5mWRme1uWdhUW3IN6DZmZxGaZSbZJBtG_3qyrLXgQAgm83_e9l_chdEbJBSWkuoyU1jUUBEhByIyzgh6gY8pZWQhG-ZfdG2ZFxQCO0EmMG5JJUsFXdMRAlDXh_BiZlW9Vb591h5dBubH3g0p-jPjRpj947fsn5R6sTTbi6XI9P_-J71WwmV701tksxeugo3ZJJetdxMp1-G7bqaSxd_g2aJWGXD1Fh0b1UX97uyfo7vev28VVsbpZXi_mq6JlFU9FK0QL-TDeNUZ1gjd0Vpd1A0BZl8fnICqolWhIJ6hQpjIzY0oKCkhLGDNsgqZ7323wf0cdkxxsbHXfK6fzrySUwAiveVVm9McHdOPH4PJ0O4oKVnLOMwV7qg0-xqCN3AY7qPAkKZG7FOQ-BZl3K19TkDSLvr9Zj82gu3-S97VngO2BmEvuQYf_vT-xfQE_OpE_</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Sattui, Sebastian E.</creator><creator>Lally, Lindsay</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20201001</creationdate><title>Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment</title><author>Sattui, Sebastian E. ; Lally, Lindsay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allergology</topic><topic>Autoimmunity (T Tarrant</topic><topic>Immunotherapy</topic><topic>Inflammatory diseases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Section Editor</topic><topic>Topical Collection on Autoimmunity</topic><topic>Vein & artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sattui, Sebastian E.</creatorcontrib><creatorcontrib>Lally, Lindsay</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Current allergy and asthma reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sattui, Sebastian E.</au><au>Lally, Lindsay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment</atitle><jtitle>Current allergy and asthma reports</jtitle><stitle>Curr Allergy Asthma Rep</stitle><addtitle>Curr Allergy Asthma Rep</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>20</volume><issue>10</issue><spage>56</spage><epage>56</epage><pages>56-56</pages><artnum>56</artnum><issn>1529-7322</issn><eissn>1534-6315</eissn><abstract>Purpose of Review
Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic in patients with granulomatosis with polyangiitis and can sometimes represent the initial or in some instances the sole manifestation. The objective of this review is to summarize the various clinical manifestations of localized disease in GPA and their treatment.
Recent Findings
Sinonasal disease is seen in up to 90% of patients. Otologic and ocular involvement is also commonly seen. Laryngeal and tracheal disease although less common is associated with significant morbidity and can be therapeutically challenging. Clinicians need to be aware of these localized GPA manifestations as they may be presenting disease features in the absence of other systemic findings. Treatment of localized GPA involves both immunosuppressive and surgical interventions for specific manifestations. Collaboration between specialists including rheumatologists, otolaryngologists, and ophthalmologists is often crucial to ensure optimal outcomes for patients.
Summary
This is a narrative review that provides a comprehensive overview of localized granulomatosis with polyangiitis and current treatment options.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32648055</pmid><doi>10.1007/s11882-020-00953-1</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1529-7322 |
ispartof | Current allergy and asthma reports, 2020-10, Vol.20 (10), p.56-56, Article 56 |
issn | 1529-7322 1534-6315 |
language | eng |
recordid | cdi_proquest_miscellaneous_2423058574 |
source | Springer Link |
subjects | Allergology Autoimmunity (T Tarrant Immunotherapy Inflammatory diseases Medicine Medicine & Public Health Monoclonal antibodies Section Editor Topical Collection on Autoimmunity Vein & artery diseases |
title | Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T23%3A54%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Localized%20Granulomatous%20with%20Polyangiitis%20(GPA):%20Varied%20Clinical%20Presentations%20and%20Update%20on%20Treatment&rft.jtitle=Current%20allergy%20and%20asthma%20reports&rft.au=Sattui,%20Sebastian%20E.&rft.date=2020-10-01&rft.volume=20&rft.issue=10&rft.spage=56&rft.epage=56&rft.pages=56-56&rft.artnum=56&rft.issn=1529-7322&rft.eissn=1534-6315&rft_id=info:doi/10.1007/s11882-020-00953-1&rft_dat=%3Cproquest_cross%3E2421634555%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-c66c26c235dbfad65b19848b2213d002526728a6b0d616af7f9ff412a20c033f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2421634555&rft_id=info:pmid/32648055&rfr_iscdi=true |